Gene · 7306
Papers3,635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,635
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Isolation of five different primary cell types from a single sample of human skin. | STAR Protoc | 2022 | 35586317 | PubTator, text mining | PubMed |
| Temporal analysis of melanogenesis identifies fatty acid metabolism as key skin pigment regulator. | PLoS Biol | 2022 | 35584084 | PubTator, text mining | PubMed |
| DUSP4 protects BRAF- and NRAS-mutant melanoma from oncogene overdose through modulation of MITF. | Life Sci Alliance | 2022 | 35580987 | PubTator, text mining | PubMed |
| CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy. | J Immunother Cancer | 2022 | 35580929 | PubTator, text mining | PubMed |
| Single-Cell Protein and Transcriptional Characterization of Epiretinal Membranes From Patients With Proliferative Vitreoretinopathy. | Invest Ophthalmol Vis Sci | 2022 | 35579905 | PubTator, text mining | PubMed |
| UVB-Induced Secretion of IL-1β Promotes Melanogenesis by Upregulating TYR/TRP-1 Expression In Vitro. | Biomed Res Int | 2022 | 35572734 | PubTator, text mining | PubMed |
| Cyano-Phycocyanin: Mechanisms of Action on Human Skin and Future Perspectives in Medicine. | Plants (Basel) | 2022 | 35567250 | PubTator, text mining | PubMed |
| The Hypopigmentation Mechanism of Tyrosinase Inhibitory Peptides Derived from Food Proteins: An Overview. | Molecules | 2022 | 35566061 | PubTator, text mining | PubMed |
| High GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition. | Cancers (Basel) | 2022 | 35565329 | PubTator, text mining | PubMed |
| Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients. | Cancers (Basel) | 2022 | 35565255 | PubTator, text mining | PubMed |
| Defining the Skeletal Myogenic Lineage in Human Pluripotent Stem Cell-Derived Teratomas. | Cells | 2022 | 35563894 | PubTator, text mining | PubMed |
| Unraveling the Molecular Basis of the Dystrophic Process in Limb-Girdle Muscular Dystrophy LGMD-R12 by Differential Gene Expression Profiles in Diseased and Healthy Muscles. | Cells | 2022 | 35563815 | PubTator, text mining | PubMed |
| Vogt-Koyanagi-Harada disease: the step-by-step approach to a better understanding of clinicopathology, immunopathology, diagnosis, and management: a brief review. | J Ophthalmic Inflamm Infect | 2022 | 35553272 | PubTator, text mining | PubMed |
| KIF13A-A Key Regulator of Recycling Endosome Dynamics. | Front Cell Dev Biol | 2022 | 35547822 | PubTator, text mining | PubMed |
Molecular Dynamics Simulation and Essential Dynamics of Deleterious Proline 12 Alanine Single-Nucleotide Polymorphism in PPARγ2 Associated with Type 2 Diabetes, Cardiovascular Disease, and Nonalcoholic Fatty Liver Disease. | PPAR Res | 2022 | 35547362 | PubTator, text mining | PubMed |
| Immune Activities in Choroids of Visually Impaired Smyth Chickens With Autoimmune Vitiligo. | Front Med (Lausanne) | 2022 | 35547230 | PubTator, text mining | PubMed |
| Diagnosis and histopathologic prognostication of canine melanocytic neoplasms: A consensus of the Oncology-Pathology Working Group. | Vet Comp Oncol | 2022 | 35522017 | PubTator, text mining | PubMed |
| The future of targeted kinase inhibitors in melanoma. | Pharmacol Ther | 2022 | 35513054 | PubTator, text mining | PubMed |
| MITF deficiency accelerates GNAQ-driven uveal melanoma. | Proc Natl Acad Sci U S A | 2022 | 35512098 | PubTator, text mining | PubMed |
| Oxidative stress in melanogenesis and melanoma development. | Contemp Oncol (Pozn) | 2022 | 35506034 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7306/papers?page=33